![Matthew Fust](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 30/06/2026
Matthew K.
Fust is currently an Independent Director at Ultragenyx Pharmaceutical, Inc. since 2014, Atara Biotherapeutics, Inc. since 2014, Crinetics Pharmaceuticals, Inc. since 2018, and Neumora Therapeutics, Inc. since 2020.
Mr. Fust is also a Director at Arsenal Biosciences, Inc. since 2021.
Former positions include Independent Director at Sunesis Pharmaceuticals, Inc. from 2011 to 2017, MacroGenics, Inc. from 2014 to 2020, and Dermira, Inc. from 2014 to 2020.
Director at BlackThorn Therapeutics, Inc. from 2017 to 2020.
Chief Financial Officer & Senior Vice President at ALZA Corp.
from 1996 to 2002.
Chief Financial Officer at Perlegen Sciences, Inc. from 2002 to 2003.
Chief Financial Officer & Executive Vice President at Jazz Pharmaceuticals, Inc. from 2003 to 2008.
Executive Vice President-Finance at Onyx Pharmaceuticals, Inc. from 2013 to 2014.
Manager-Healthcare Strategy Practice at Anderson Consulting Team in 1996.
Education includes an undergraduate degree from the University of Minnesota in 1986 and an MBA from Stanford Graduate School of Business in 1991.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/05/2026 | 33.696 ( 0,03% ) | 1 M $ | 30/06/2026 | |
| 08/07/2026 | 22.836 ( 0,02% ) | 854 523 $ | 30/06/2026 | |
| 09/06/2026 | 30.188 ( 0,34% ) | 346 558 $ | 30/06/2026 | |
| 27/05/2026 | 20.100 ( 0,01% ) | 34 170 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Direttore/Membro del Consiglio | 01/01/2014 |
| ATARA BIOTHERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/03/2014 |
| CRINETICS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/02/2018 |
| NEUMORA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/12/2020 |
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Direttore/Membro del Consiglio | 08/03/2021 |
| Società | Posizione | Fine |
|---|---|---|
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Direttore/Membro del Consiglio | 01/06/2020 |
| MACROGENICS, INC. | Direttore/Membro del Consiglio | 14/05/2020 |
| DERMIRA, INC. | Direttore/Membro del Consiglio | 20/02/2020 |
| VIRACTA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/01/2017 |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 16 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Discovers and develops drugs | Retail Trade |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Anderson Consulting Team
 Anderson Consulting Team Movies/EntertainmentConsumer Services Provides event planning services | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Health Technology |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
